1. Home
  2. REVB vs UONE Comparison

REVB vs UONE Comparison

Compare REVB & UONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$0.63

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo Urban One Inc.

UONE

Urban One Inc.

HOLD

Current Price

$10.13

Market Cap

4.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
REVB
UONE
Founded
2020
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REVB
UONE
Price
$0.63
$10.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.3M
9.3K
Earning Date
03-05-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$393,670,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$8.60
52 Week High
$17.04
$19.00

Technical Indicators

Market Signals
Indicator
REVB
UONE
Relative Strength Index (RSI) 30.42 96.95
Support Level $0.71 $0.86
Resistance Level $0.96 $1.21
Average True Range (ATR) 0.14 0.29
MACD -0.01 0.58
Stochastic Oscillator 4.73 83.14

Price Performance

Historical Comparison
REVB
UONE

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About UONE Urban One Inc.

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: